Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ERBB3 mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

ERBB3 mutation	Gallbladder Cancer	ERBB3 mutation	Gallbladder Cancer	lapatinib Sensitive: C3 – Early Trials lapatinib Sensitive : C3	lapatinib Sensitive: C3 – Early Trials lapatinib Sensitive : C3
ERBB3 mutation	Gallbladder Cancer	ERBB3 mutation	Gallbladder Cancer	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3
ERBB3 mutation	Urothelial Cancer	ERBB3 mutation	Urothelial Cancer	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3
ERBB3 mutation	Squamous Cell Carcinoma of Head and Neck	ERBB3 mutation	Squamous Cell Carcinoma of Head and Neck	cetuximab + ISU104 Sensitive: C3 – Early Trials cetuximab + ISU104 Sensitive : C3	cetuximab + ISU104 Sensitive: C3 – Early Trials cetuximab + ISU104 Sensitive : C3
ERBB3 mutation	Colorectal Cancer	ERBB3 mutation	Colorectal Cancer	regorafenib Sensitive: C3 – Early Trials regorafenib Sensitive : C3	regorafenib Sensitive: C3 – Early Trials regorafenib Sensitive : C3
ERBB3 mutation	Breast Cancer	ERBB3 mutation	Breast Cancer	U3-1402 Sensitive: D – Preclinical U3-1402 Sensitive : D	U3-1402 Sensitive: D – Preclinical U3-1402 Sensitive : D